Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.
Alblihy A, Ali R, Algethami M, Shoqafi A, Toss MS, Brownlie J, Tatum NJ, Hickson I, Moran PO, Grabowska A, Jeyapalan JN, Mongan NP, Rakha EA, Madhusudan S.
Alblihy A, et al. Among authors: toss ms.
NPJ Precis Oncol. 2022 Jul 19;6(1):51. doi: 10.1038/s41698-022-00298-0.
NPJ Precis Oncol. 2022.
PMID: 35853939
Free PMC article.